INTERNATIONAL PATENT: JUNLI PHARMACEUTICALS (WUXI) CO., LTD., 竣莅医药科技（无锡）有限公司 FILES APPLICATION FOR "RNA INTERFERENCE TRIGGER MOLECULE AND CORRESPONDING NUCLEIC ACID INTERFERENCE PHARMACEUTICAL PREPARATION AND USE THEREOF"

GENEVA, Sept. 15 -- JUNLI PHARMACEUTICALS (WUXI) CO., LTD. (C513-1 Xingye Building, 97-1 Linghu Avenue, Xinwu DistrictWuxi, Jiangsu 214142), 竣莅医药科技（无锡）有限公司 (中国江苏省无锡市新吴区菱湖大道97-1兴业楼C513-1) filed a patent application (PCT/CN2024/080614) for "RNA INTERFERENCE TRIGGER MOLECULE, AND CORRESPONDING NUCLEIC ACID INTERFERENCE PHARMACEUTICAL PREPARATION AND USE THEREOF" on Mar 07, 2024. With publication no. WO/2025/184876, the details related to the patent application was published on Sep 11, 2025.

Notably, the patent application ...